Overview
Publication Venue For
Chronobiological influence over cardiovascular function the good, the bad, and the ugly.
258-279.
2020
Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.
125:957-968.
2019
Response by Pfeffer et al to Letter Regarding Article, "heart Failure with Preserved Ejection Fraction in Perspective".
125:E26.
2019
Heart Failure with Preserved Ejection Fraction in Perspective.
124:1598-1617.
2019
Treatment of Resistant and Refractory Hypertension.
124:1061-1070.
2019
Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.
124:161-169.
2019
Lower blood pressure thresholds raise the bar in pregnancy.
125:195-197.
2019
Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcription.
125:152-166.
2019
Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.
122:958-969.
2018
E2F1 suppresses oxidative metabolism and endothelial differentiation of bone marrow progenitor cells.
122:701-711.
2018
CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
122:88-96.
2018
Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission.
122:58-73.
2018
Can we engineer a human cardiac patch for therapy?.
123:244-265.
2018
Effective metabolic approaches for the energy starved failing heart: Bioenergetic resiliency via redundancy or something else?.
123:329-331.
2018
Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine.
122:199-201.
2018
Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication.
123:100-106.
2018
Multifunctional role of chymase in acute and chronic tissue injury and remodeling.
122:319-336.
2018
Relationship between the efficacy of cardiac cell therapy and the inhibition of differentiation of human iPSC-Derived nonmyocyte cardiac cells into Myofibroblast-like cells.
123:1313-1325.
2018
Sprinting toward the optimal blood pressure target for hypertensive patients.
123:531-534.
2018
Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b.
123:564-578.
2018
PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.
121:1370-1378.
2017
Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium.
120:1709-1712.
2017
Immunomodulation is the key to cardiac repair.
120:1530-1532.
2017
Myocardial Tissue Engineering with Cells Derived from Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.
120:1318-1325.
2017
Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.
120:e7-e23.
2017
Reprogrammed Human Endothelial Cells.
120:756-758.
2017
From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues.
120:150-165.
2017
A special report on the NHLBI initiative to study cellular and molecular mechanisms of arterial stiffness and its association with hypertension.
121:1216-1218.
2017
Lactate promotes synthetic phenotype in vascular smooth muscle cells.
121:1251-1262.
2017
Crossing into the Next Frontier of Cardiac Extracellular Matrix Research.
119:1040-1045.
2016
Meeting Report for NIH 2016 Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering 2016.
119:981-983.
2016
Response by Zhou et al to Letter Regarding Article, Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.
119:e29-e30.
2016
The biological basis for cardiac repair after myocardial infarction.
119:91-112.
2016
Assessing Cardiac Metabolism.
118:1659-1701.
2016
Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy.
118:1208-1222.
2016
Long-Term Outcome of Administration of c-kitPOS Cardiac Progenitor Cells after Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.
118:1091-1105.
2016
A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: Paracrine activity without remuscularization.
118:970-983.
2016
CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels..
118:230-240.
2016
The Nervous Heart.
117:980-981.
2015
Abstract 221: Chronic Alterations of the Tissue Dendritic Cell and Macrophage Network Underlies the Th1 Response in the Failing Heart.
111:A221.
2015
Abstract 90: The Spleen Is an Essential Regulator of Systemic Neovascularization In Vivo.
111:A90.
2015
Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury.
117:437-449.
2015
Bach1 represses Wnt/β-catenin signaling and angiogenesis.
117:364-375.
2015
Embryonic Stem Cell-Derived Exosomes Promote Endogenous Repair Mechanisms and Enhance Cardiac Function Following Myocardial Infarction.
117:52-64.
2015
New Approaches in the Treatment of Hypertension.
116:1074-1095.
2015
The GSK-3 family as therapeutic target for myocardial diseases.
116:138-149.
2015
Abstract 60: The Role of Mononuclear Phagocytes in Pressure Overload Heart Failure.
115:A60.
2014
PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle.
115:504-517.
2014
OxLDL Triggers Retrograde Translocation of Arginase2 in Aortic Endothelial Cells via ROCK and Mitochondrial Processing Peptidase.
115:450-459.
2014
Sorafenib cardiotoxicity increases mortality after myocardial infarction.
114:1700-1712.
2014
Activation of AKT by O-linked N-Acetylglucosamine induces vascular calcification in diabetes mellitus.
114:1094-1102.
2014
It takes two to tango: Monocyte and macrophage duality in the infarcted heart.
114:1558-1560.
2014
Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure critical importance of the cardiosplenic axis.
114:266-282.
2014
Patching the heart: Cardiac repair from within and outside.
113:922-932.
2013
Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.
111:1176-1189.
2012
Metabolic remodeling in the hypertrophic heart: Fuel for thought.
111:666-668.
2012
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.
111:543-552.
2012
Bioenergetic and functional consequences of cellular therapy: Activation of endogenous Cardiovascular progenitor cells.
111:455-468.
2012
Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair.
111:180-190.
2012
Orai1 determines calcium selectivity of an endogenous trpc heterotetramer channel.
110:1435-1444.
2012
Elucidating nature's solutions to heart, lung, and blood diseases and sleep disorders.
110:915-921.
2012
Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles.
110:727-738.
2012
Response to the letter by Edwards et al.
110.
2012
Animal models of heart failure a scientific statement from the American Heart Association.
111:131-150.
2012
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.
109:1259-1268.
2011
Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.
109:1280-1289.
2011
PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
109:783-793.
2011
Translational success stories: Angiotensin receptor 1 antagonists in heart failure.
109:437-452.
2011
Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition.
108:1093-1101.
2011
ATP production rate via creatine kinase or ATP synthase in Vivo: A novel superfast magnetization saturation transfer method.
108:653-663.
2011
Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart.
108:437-445.
2011
Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.
108:279-283.
2011
Late-breaking basic science abstracts from the American Heart Association's Scientific Sessions 2010.
107.
2010
PGC-1 coactivators in cardiac development and disease.
107:825-838.
2010
Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.
107:242-251.
2010
Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARα.
107:233-241.
2010
Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.
107:117-125.
2010
Glycogen synthase kinase-3β regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
106:1635-1645.
2010
Peroxisome proliferator-activated receptor δ is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.
106:911-919.
2010
Career moves: Induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.
106:7-9.
2010
Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.
105:965-972.
2009
Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.
105:897-905.
2009
Direct Relationship Between Protein O-GlcNAcylation and the Cardiomyocyte Circadian Clock.
105:E50-E50.
2009
Increased Cardiomyocyte 0-linked-beta-N-acetylglucosamine (0-GlcNAc) Levels Induced by Glucose Deprivation Mediated by Decreased 0-GlcNAcase Expression and Reduced Hexosamine Biosynthesis Flux.
105:E34-E35.
2009
O-linked-beta-N-acetylglucosamine (O-GlcNAc) Mediated Ischemic Cardioprotection Associated with Increased O-GlcNAcylation of Cytoskeletal Z-Line Proteins.
105:E13-E13.
2009
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury.
104:1012-1020.
2009
IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.
104.
2009
Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
104:41-49.
2009
Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.
102.
2008
Endothelial arginase II: A novel target for the treatment of atherosclerosis.
102:923-932.
2008
Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4.
102:966-974.
2008
Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
102:185-192.
2008
Role of mitochondrial dysfunction in insulin resistance.
102:401-414.
2008
Heme-Egr-1: New partners in atherosclerotic progression?.
102:6-8.
2008
Inducible NO synthase-dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction.
101:692-702.
2007
Myocardial Smad4 is essential for cardiogenesis in mouse embryos.
101:277-285.
2007
Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis.
100:1703-1711.
2007
Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis.
100:874-883.
2007
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration.
100:654-661.
2007
Myocyte nitroso-redox imbalance in sepsis: NO simple answer.
100:1-4.
2007
The role of O-GlcNAcylation in aging-related loss of estrogenic vasoprotection.
99:1282-1282.
2006
APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2.
99:829-836.
2006
Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells.
99:924-932.
2006
Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling.
99:951-960.
2006
Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.
98:1098-1105.
2006
Coupled and uncoupled NOS: Separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling.
98:717-719.
2006
Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity.
98:119-124.
2006
Activation of the endothelial store-operated ISOC Ca 2+ channel requires interaction of protein 4.1 with TRPC4.
97:1164-1172.
2005
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I.
97:1085-1086.
2005
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
97:524-532.
2005
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.
97:236-243.
2005
Glucosamine-induced cardioprotection mediated by the hexosamine biosynthesis pathway and increased levels of O-linked N-acetylglucosamine on nucleocytoplasmic proteins.
97:E28-E28.
2005
Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability determinants of the vascular leak site.
96:856-863.
2005
Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.
96:864-872.
2005
Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat.
96:277-279.
2005
Cytokine-induced modulation of cardiac function.
95:1140-1153.
2004
Apurinic/apyrmidinic endonuclease 1 regulates endothelial NO production and vascular tone.
95:902-910.
2004
Antiinflammatory properties of HDL.
95:764-772.
2004
How do red blood cells dilate blood vessels?--Reply..
95.
2004
Effects of electrical shocks on Cai2+ and V m in myocyte cultures.
94:1589-1597.
2004
Nitric oxide protects against pathological ventricular remodeling: Reconsideration of the role of NO in the failing heart.
94:1155-1157.
2004
Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on β2-Adrenergic Receptor Signaling.
94:1091-1100.
2004
Genome-Wide Scan Identifies Novel QTLs for Cholesterol and LDL Levels in F2[Dahl RxS] Intercross Rats.
94:446-452.
2004
Nonlinear Changes of Transmembrane Potential, during Electrical Shocks: Role of Membrane Electroporation.
94:208-214.
2004
CaV3.1 (α1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation.
93:346-353.
2003
Nitric oxide regulation of myocardial contractility and calcium cycling: Independent impact of neuronal and endothelial nitric oxide synthases.
92:1322-1329.
2003
Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
92:741-748.
2003
Sustained reentry in the left ventricle of fibrillating pig hearts.
92:539-545.
2003
Vectorial sodium transport across the mammalian alveolar epithelium: It occurs but through which cells?.
92:348-349.
2003
Regional differences in ventricular fibrillation in the open-chest porcine left ventricle.
91:733-740.
2002
Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs.
91:626-632.
2002
Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.
91:165-172.
2002
Optical mapping of arrhythmias induced by strong electrical shocks in myocyte cultures.
90:664-670.
2002
Recent fibrillation studies: Attempts to wrest order from disorder.
89:1089-1091.
2001
Nitric oxide synthase (NOS2) mutation in Dahl/Rapp rats decreases enzyme stability.
89:317-322.
2001
Autonomous and growth factor - Induced hypertrophy in cultured neonatal mouse cardiac myocytes: Comparison with rat.
87:781-788.
2000
Nonlinear changes of transmembrane potential during defibrillation shocks: Role of Ca2+ current.
87:453-459.
2000
Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells.
86:960-966.
2000
Fibrillating myocardium: Rabbit warren or beehive?.
86:369-370.
2000
Identification of
cis
Elements in the Cardiac Troponin T Gene Conferring Specific Expression in Cardiac Muscle of Transgenic Mice.
86:478-484.
2000
The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src.
84:1332-1338.
1999
Chemiluminescent detection of oxidants in vascular tissue: Lucigenin but not coelenterazine enhances superoxide formation.
84:1203-1211.
1999
Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs.
84:945-954.
1999
Spatial changes in the transmembrane potential during extracellular electric stimulation.
83:1003-1014.
1998
Importance of E-selectin for firm leukocyte adhesion in vivo.
83:287-294.
1998
ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.
82:346-359.
1998
Activation of cardiac tissue by extracellular electrical shocks: Formation of 'secondary sources' at intercellular clefts in monolayers of cultured myocytes.
82:375-385.
1998
Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells.
82:139-146.
1998
Cross talk between angiotensin AT1 and α1-adrenergic receptors: Angiotensin II downregulates α(1a)-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes.
81:396-403.
1997
Anisotropic Activation Spread in Heart Cell Monolayers Assessed by High-Resolution Optical Mapping: Role of Tissue Discontinuities.
79:115-127.
1996
Functional and structural assessment of intercellular communication: Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes.
79:174-183.
1996
Spatial changes in transmembrane potential during extracellular electrical shocks in cultured monolayers of neonatal rat ventricular myocytes.
79:676-690.
1996
23Na and 31P nuclear magnetic resonance studies of ischemia-induced ventricular fibrillation. Alterations of intracellular Na+ and cellular energy..
77:394-406.
1995
Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.
77:335-341.
1995
Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure..
75:347-356.
1994
Anisotropic conduction in monolayers of neonatal rat heart cells cultured on collagen substrate.
75:591-595.
1994
Cloning of the rat α(1C)-adrenergic receptor from cardiac myocytes: α(1C), α(1B), and α(1D) mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.
75:796-802.
1994
Computer simulations of three-dimensional propagation in ventricular myocardium: Effects of intramural fiber rotation and inhomogeneous conductivity on epicardial activation.
72:744-756.
1993
Coronary pressure-flow relation in left ventricular hypertrophy: Importance of changes in back pressure versus changes in minimum resistance.
72:579-587.
1993
Microscopic conduction in cultured strands of neonatal rat heart cells measured with voltage-sensitive dyes.
73:914-925.
1993
Kinetics of restitution of left ventricular relaxation.
70:29-38.
1992
Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.
69:1427-1449.
1991
Correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis.
67:660-673.
1990
Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat.
66:1127-1132.
1990
Differences in the electrophysiological response to canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium.
67:615-627.
1990
Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts.
67:948-959.
1990
Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load.
66:84-102.
1990
Vagally induced block and delayed conduction as a mechanism for circus movement tachycardia in frog atria.
64:213-226.
1989
Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.
64:1127-1136.
1989
Transient outward current prominent in canine ventricular epicardium but not endocardium.
62:116-126.
1988
Sympathetic innervation alters growth and intrinsic heart rate of fetal rat atria maturing in oculo.
59:534-544.
1986
Histamine H1 receptor antagonists inhibit autoregulation of renal blood flow in the dog.
54:527-535.
1984
Effect of acute hypoxia on the pulmonary conversion of angiotensin I to angiotensin II in dogs.
46:221-226.
1980
Autoregulatory responses of superficial nephrons and their association with sodium excretion during arterial pressure alterations in the dog.
41:487-496.
1977
Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.
40:428-434.
1977
Relation of renal hemodynamics to metabolism of angiotensin II by the canine kidney.
41:283-287.
1977
Structural requirements for substrates and inhibitors of angiotensin I converting enzyme in vivo and in vitro.
34:19-26.
1974
Mechanism of renal handling of angiotensin II in the dog.
33:500-507.
1973
Substrate requirements for angiotensin I conversion in vivo and in vitro..
32:415-423.
1973
Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog..
29:682-690.
1971
In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood..
26:591-599.
1970
